More than 40% of GC patients express PD-L1 in gastric carcinoma tissues, and the expression of PD-L1 is significantly correlated to tumor size, invasion, lymph node metastasis (LNM), and survival time of patients (42). The gene discussed is CD274; the disease is neoplasm.